Sorry, the video is currently unavailable.
Drs. Ron Waksman and Renato Lopes discuss the results of the BRACE CORONA study, which was presented as a late-breaking trial at the European Society of Cardiology virtual congress. The study examined the difference between continuing or suspending ACE inhibitors and angiotensin receptor blockers in COVID-19 patients. Dr. Lopes provides insights into the top-line findings, which is that there were no significant differences between the two treatment regimens.